Major Growth Drivers: Growth in this market is driven by the rising global prevalence of hematologic cancer, growing awareness regarding personalized medicines, and increasing collaborations for developing new assays. On the other hand, Uncertain reimbursement scenario in different regions is expected to restrain the growth of this market during the forecast period. Expected Revenue Growth: [116 Pages Report] The hemato oncology testing market is projected to reach … Continue reading Hemato – Oncology Testing Market Worth USD 4.0 Billion : Increasing Incidence Of Hematologic Cancer